Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

oligodendroglial tumor - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

oligodendroglial tumor

MONDO:0018744

Also known as:oligodendroglial neoplasm

Find Clinical TrialsTrials

Overview

Oligodendrogliomas are cerebral tumors that are differentiated from other gliomas on the basis of their unique genetic characteristics and better response to chemotherapy. These tumors are classified according to their grade (low grade oligodendrogliomas: grade II of the WHO classification and anaplastic oligodendrogliomas: grade III of the WHO classification) and according to their pure or mixed histology (oligoastrocytomas).

Clinical Trials1 registered · 1 recruiting

ResearchLimited published research (3 articles)

Diagnosis

Biomarker and diagnostic research for oligodendroglial tumor has been reported in the published literature.

Prognosis

Estimated prevalence: Unknown (Unknown prevalence).

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

1 clinical trial registered, 1 recruiting. Interventions under study include drug therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.

3 publications have been identified in PubMed for oligodendroglial tumor. Research spans Clinical Trial Publication (67%) and Diagnostic / Biomarker (33%).

Recent Publications

Blakeley J (2025). [PMID: 40304440](https://pubmed.ncbi.nlm.nih.gov/40304440/). *Neuro-oncology*. [Clinical Trial Publication]
Blakeley J (2025). [PMID: 40300117](https://pubmed.ncbi.nlm.nih.gov/40300117/). *Journal of clinical oncology : official journal of the American Society of Clinical Oncology*. [Clinical Trial Publication]
Mannil M (2024). [PMID: 39067267](https://pubmed.ncbi.nlm.nih.gov/39067267/). *European journal of radiology*. [Diagnostic / Biomarker]

Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 1:17 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:46484

GARD

Genetic and Rare Diseases Info Center

GARD:13156

Questions for Your Care Team

→Are any of the 1 active clinical trial a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

oligodendroglial tumor

Overview

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team